chrX-102654173-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_001184727.2(GPRASP1):c.260G>A(p.Arg87Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,211,151 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001184727.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP1 | NM_001184727.2 | c.260G>A | p.Arg87Gln | missense_variant | 6/6 | ENST00000537097.2 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.649+48520G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP1 | ENST00000537097.2 | c.260G>A | p.Arg87Gln | missense_variant | 6/6 | 2 | NM_001184727.2 | P1 | |
ENST00000602441.1 | n.58-4459C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 3AN: 113032Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35166
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183464Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67896
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1098119Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363477
GnomAD4 genome AF: 0.0000265 AC: 3AN: 113032Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35166
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at